Pilot Study Targeting Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer As Part of Adjuvant Therapy and Preventive Strategy.
Phase of Trial: Phase II
Latest Information Update: 03 Mar 2015
At a glance
- Drugs Azacitidine (Primary) ; Carboplatin; Cisplatin; Docetaxel; Paclitaxel; Pegfilgrastim; Pemetrexed; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Biomarker; Therapeutic Use
- 23 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 05 Oct 2010 New trial record